JDD Article Highlights
Vitiligo research is often inconsistent when it comes to measuring disease severity, making it challenging to compare treatment outcomes. The IDEOM Vitiligo Workgroup has begun efforts to improve the standardization of vitiligo severity reporting in clinical trials. This JDD article discusses various grading systems in place, including body surface area (BSA) scores and repigmentation scales, new metrics such as treatment burden and cost-effectiveness are now being explored to provide a more comprehensive understanding.
